Cerebras Systems made a forceful entrance to the public market, pricing its Nasdaq IPO at $135 a share and raising about $3.5 billion before fees, one of the largest U.S. listings of 2026. The price came at the top of a revised range after strong demand during the roadshow, giving the AI chipmaker an implied valuation of roughly $34.7 billion. For investors looking beyond Nvidia in the race to supply the computing backbone of artificial intelligence, the debut stands out as a major test of appetite for alternative chip architectures.
The company had initially marketed 28 million Class A shares at $115 to $125, then lifted the range to $125 to $135 days before pricing. That move underscored the market’s willingness to back companies tied to the buildout of AI infrastructure, even at elevated valuations. Cerebras is pitching a distinct approach: wafer-scale chips designed to combine compute, memory and bandwidth on a single massive processor, reducing the bottlenecks that can arise in conventional multi-chip systems.
Its financial profile helped support the story. Cerebras reported $510 million in revenue for 2025, up 76% from $290 million a year earlier, and said it reached profitability for the first time in its 11-year history. Part of the improvement came from restructuring a prior transaction with Abu Dhabi-based G42, which had weighed on 2024 results. More significant for investors, though, was the scale of future demand outlined in the filing.
Cerebras disclosed a $24.6 billion order backlog, anchored by a December 2025 agreement with OpenAI worth more than $20 billion over three years. The deal covers chips and computing capacity, including up to 750 megawatts of AI compute through 2028, with options for far more later in the decade. OpenAI also received warrants that could eventually give it as much as a 10% stake in the company. That backlog gives Cerebras unusual visibility for a newly listed hardware company, but it also sharpens concerns about customer concentration.
That issue remains one of the clearest risks in the investment case. Cerebras’ earlier failed IPO attempt in 2024 was overshadowed by reliance on G42, which at one point accounted for the vast majority of revenue. The customer mix has changed, but dependence on a small number of large buyers is still a vulnerability, particularly in a capital-intensive market where spending plans can shift quickly. The competitive backdrop is equally tough. Nvidia remains dominant, while AMD, Intel and a growing field of specialist chip companies are chasing the same wave of demand.
Even so, the listing lands at a moment when investors are still willing to pay for scarce AI infrastructure assets with credible growth. Cerebras’ IPO valuation is well above the roughly $23 billion level from a February funding round, reflecting both momentum in AI markets and confidence that large customers want alternatives to the incumbent supply chain. The proceeds give the company room to expand manufacturing, invest in new generations of wafer-scale systems and try to turn technical differentiation into durable commercial scale.
The next phase will matter more than the debut. Investors will be watching whether Cerebras can convert backlog into recognized revenue, preserve margins as it ramps production and broaden its customer base beyond a handful of headline names. If it executes, the IPO could mark the emergence of a serious new contender in AI hardware. If not, it risks becoming another richly valued bet in one of the market’s most crowded and demanding sectors.